本项目在已验证HER2/neuP185蛋白免疫原性的基础上,通过基因工程技术克隆并构建HER2/neu(cerbB-2)原癌基因及其片段的表达载体,将质粒DNA直接免疫小鼠,利用内源性MHC抗原呈递系统,寻找有效抗瘤效应的亚优势抗原表位,打破机体对P185蛋白的耐受状态,通过主动免疫盏?有限而特异的抗瘤免疫应答,为肿瘤DNA疫苗的研究及应用提供实验基础和科学依据。
{{i.achievement_title}}
数据更新时间:2023-05-31
An improved extraction method reveals varied DNA content in different parts of the shells of Pacific oysters
DNA storage: research landscape and future prospects
The effectiveness and safety of traditional Chinese herbal medicine for the treatment of male infertility associated with sperm DNA fragmentation
KLF14/miR‐1283/TFAP2C axis inhibits HER2‐positive breast cancer progression via declining tumor cell proliferation
Modeling the relationship of diverse genomic signatures to gene expression levels with the regulation of long-range enhancer-promoter interactions
HER2/NEU瘤苗主动免疫诱导特异抗瘤效应的研究
抗体导向的新型HER2/neu肿瘤疫苗研究
HER2/neu受体酪氨酸激酶选择性抑制剂及其抗瘤作用研究
携带Her2/neu的红细胞作为抗乳腺癌疫苗的作用和免疫机制